Stock Track | Chemours Plunges 9.90% in Pre-Market Following Disappointing Earnings Results and Widened Losses

Stock Track

Feb 20

Chemours Company (CC) shares plunged 9.90% in pre-market trading, continuing the negative momentum from the previous session's after-hours decline.

The sharp drop follows the chemical company's release of disappointing fourth-quarter and full-year 2025 financial results that significantly missed analyst expectations. The company reported weaker-than-expected performance across key metrics, including earnings per share and revenue.

Chemours' Q4 adjusted earnings per share of $0.05 fell short of the consensus estimate of $0.07, while quarterly sales of $1.300 billion also missed expectations. More concerning to investors was the widening of the net loss attributable to shareholders to $47 million, a substantial increase from the $11 million loss reported a year earlier. The company attributed the poor performance to volume declines in its titanium technologies and advanced performance materials businesses due to weaker cyclically-sensitive end markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1124094775"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124094775\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124094775?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124094775","market":"us","top_or_hot":-1,"title":"Stock Track | Chemours Plunges 9.90% in Pre-Market Following Disappointing Earnings Results and Widened Losses","media":"Stock Track","content":"<p>Chemours Company (CC) shares plunged 9.90% in pre-market trading, continuing the negative momentum from the previous session's after-hours decline.</p><p>The sharp drop follows the chemical company's release of disappointing fourth-quarter and full-year 2025 financial results that significantly missed analyst expectations. The company reported weaker-than-expected performance across key metrics, including earnings per share and revenue.</p><p>Chemours' Q4 adjusted earnings per share of $0.05 fell short of the consensus estimate of $0.07, while quarterly sales of $1.300 billion also missed expectations. More concerning to investors was the widening of the net loss attributable to shareholders to $47 million, a substantial increase from the $11 million loss reported a year earlier. The company attributed the poor performance to volume declines in its titanium technologies and advanced performance materials businesses due to weaker cyclically-sensitive end markets.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Chemours Plunges 9.90% in Pre-Market Following Disappointing Earnings Results and Widened Losses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Chemours Plunges 9.90% in Pre-Market Following Disappointing Earnings Results and Widened Losses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chemours Company (CC) shares plunged 9.90% in pre-market trading, continuing the negative momentum from the previous session's after-hours decline.</p><p>The sharp drop follows the chemical company's release of disappointing fourth-quarter and full-year 2025 financial results that significantly missed analyst expectations. The company reported weaker-than-expected performance across key metrics, including earnings per share and revenue.</p><p>Chemours' Q4 adjusted earnings per share of $0.05 fell short of the consensus estimate of $0.07, while quarterly sales of $1.300 billion also missed expectations. More concerning to investors was the widening of the net loss attributable to shareholders to $47 million, a substantial increase from the $11 million loss reported a year earlier. The company attributed the poor performance to volume declines in its titanium technologies and advanced performance materials businesses due to weaker cyclically-sensitive end markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CC","symbol_name":"Chemours Company","start_time":0,"source_url":"","article_id":"1124094775","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124094775","pubTimestamp":1771589072,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Chemours Company (CC) shares plunged 9.90% in pre-market trading, continuing the negative momentum from the previous session's after-hours decline.The sharp drop follows the chemical company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CC":"Chemours Company"},"translate_title":"个股追踪|财报令人失望亏损扩大科慕盘前暴跌9.90%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CC":1},"content_text":"Chemours Company (CC) shares plunged 9.90% in pre-market trading, continuing the negative momentum from the previous session's after-hours decline.The sharp drop follows the chemical company's release of disappointing fourth-quarter and full-year 2025 financial results that significantly missed analyst expectations. The company reported weaker-than-expected performance across key metrics, including earnings per share and revenue.Chemours' Q4 adjusted earnings per share of $0.05 fell short of the consensus estimate of $0.07, while quarterly sales of $1.300 billion also missed expectations. More concerning to investors was the widening of the net loss attributable to shareholders to $47 million, a substantial increase from the $11 million loss reported a year earlier. The company attributed the poor performance to volume declines in its titanium technologies and advanced performance materials businesses due to weaker cyclically-sensitive end markets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}